The Future of CAR-T

A New Kind of CAR-T

JURA Bio is developing a novel therapeutic platform of CAR-T cell-based therapies with the needs of autoimmune patients in mind: a shifted safety-efficacy profile, components that have been validated in clinic, and state-of-the-art targeting that enables therapeutic interventions at multiple disease stages.